Connecticut Considers MMJ Access for Children
In many state legislatures across the country, lawmakers are debating medical marijuana. For the most part, the question that hangs over our elected representatives is whether or not they should legalize the substance; however, in Connecticut, lawmakers are debating whether to expand access to children.
Raised Bill No. 1064 would expand the definition of a “qualifying patient” to include persons under the age of 18, provided that they have permission from a parent and a recommendation from a physician who has treated their debilitating condition before. Most recently, the General Assembly’s Judiciary Committee held a hearing to allow Connecticut parents and citizens voice their support and concerns.
Many lawmakers at the hearing were touched by the stories told by parents who had to leave Connecticut to treat their children’s disease and how medical marijuana can help them. One representative, William Tong, was ardently against expanding the state’s medical marijuana program but the heartfelt testimony changed his position.
“I think it is going to be one of the more important things we do this year,” Tong said at the meeting. “I have my children foremost in mind when I make these remarks.” It is amazing how someone’s opinion of medical marijuana can change when they meet someone who actually uses it.
Naturally, not everyone was convinced by the compelling testimony heard in the committee. When the Judiciary Committee reconvened to hold a vote on the bill, Republican Sen. Toni Boucher railed against the measure in an hour-long monologue, proving brevity is the soul of wit.
Boucher argued, “Our continued attempts to blur the line between the use of [an] addictive drug and the use of it as a medicine really undercuts the goals of stopping … drug use, preventing addiction and promoting really good health for our children.”
What Boucher failed to notice is that plenty of states, like Colorado, have already allowed children to use medical marijuana; and none of these states have yet fallen into a landscape ravaged by drug-addled biker gangs of children. Thankfully, few listened to Boucher’s desperate rant.
The Judiciary Committee approved the bill with a vote of 29-15 and now it moves on to the full Senate for consideration. If passed, RB 1064 would be a win-win for everyone involved. Children in suffering will be able to get the medicine they need, the medical marijuana industry will expand just a little bit, and politicians get to look like they care about the state’s youth.
Undoubtedly, there will be resistance in the Senate, but it will be hard for opponents to employ the “think of the children” act when actual children are stare at them and say, “Please, may I have my medicine?”
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer